跳至主導覽 跳至搜尋 跳過主要內容

Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program

  • Tsung Hsien Chiang
  • , Shu Lin Chuang
  • , Sam Li Sheng Chen
  • , Han Mo Chiu
  • , Amy Ming Fang Yen
  • , Sherry Yueh Hsia Chiu
  • , Jean Ching Yuan Fann
  • , Chu Kuang Chou
  • , Yi Chia Lee*
  • , Ming Shiang Wu
  • , Hsiu Hsi Chen
  • *此作品的通信作者
  • National Taiwan University
  • Taipei Medical University
  • Kainan University
  • Chia-Yi Christian Hospital

研究成果: 期刊稿件 › 文章 › 同行評審

102 引文 斯高帕斯(Scopus)

摘要

BACKGROUND & AIMS: We investigated whether 2 quantitative fecal immunochemical tests (FITs) with the same cutoff concentration of fecal hemoglobin perform equivalently in identifying patients with colorectal cancer (CRC).

METHODS: A total of 956,005 Taiwanese subjects, 50 to 69 years old, participated in a nationwide CRC screening program to compare results from 2 FITs; 78% were tested using the OC-Sensor (n = 747,076; Eiken Chemical Co, Tokyo, Japan) and 22% were tested using the HM-Jack (n = 208,929; Kyowa Medex Co Ltd, Tokyo, Japan), from 2004 through 2009. The cutoff concentration for a positive finding was 20 μg hemoglobin/g feces, based on a standardized reporting unit system. The tests were compared using short-term and long-term indicators of performance.

RESULTS: The OC-Sensor test detected CRC in 0.21% of patients, with a positive predictive value of 6.8%. The HM-Jack test detected CRC in 0.17% of patients, with a positive predictive value of 5.2%. The rate of interval cancer rate was 30.7/100,000 person-years among subjects receiving the OC-Sensor test and 40.6/100,000 person-years among those receiving the HM-Jack test; there was significant difference in test sensitivity (80% vs 68%, P =.005) that was related to the detectability of proximal CRC. After adjusting for differences in city/county, age, sex, ambient temperature, and colonoscopy quality, significant differences were observed between the tests in the positive predictive value for cancer detection (adjusted relative risk = 1.29; 95% confidence interval, 1.14-1.46) and the rates of interval cancer (0.75; 95% confidence interval, 0.62-0.92). Although each test was estimated to reduce CRC mortality by approximately 10%, no significant difference in mortality was observed when the 2 groups were compared.

CONCLUSIONS: Different brands of quantitative FITs, even with the same cutoff hemoglobin concentration, perform differently in mass screening. Population-level data should be gathered to verify the credibility of quantitative laboratory findings.

原文英語
頁(從 - 到)1317-1326
頁數10
期刊Gastroenterology
卷147
發行號6
DOIs
出版狀態已出版 - 01 12 2014

文獻附註

Publisher Copyright:
© 2014 AGA Institute.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program」主題。共同形成了獨特的指紋。

引用此